Yenidoğan Yoğun Bakımında Yedi Yıllık Diyabetik Anne Bebeği Deneyimi

Öz

Amaç: Diyabet, gebelik süresince fetal gelişimi olumsuz etkileyen, yenidoğanlarda metabolik bozukluklara yol açan önemli bir hastalıktır. Çalışmamızda, diyabetik anne bebeklerinde gelişen metabolik ve sistemik komplikasyonların gebelik takipleri ile birlikte değerlendirilmesi amaçlanmıştır.Gereç ve Yöntem: Ocak 2005-Aralık 2011 yılları arasında kliniğimizde diyabetik anne bebeği DAB tanısı ile izlenmiş yenidoğan bebeklerde klinik bulgular ve laboratuvar verileri, annelere ait demografik özellikler incelendi.Bulgular: Çalışma süresi içerisinde 86 yenidoğan DAB tanısı aldı. Bu bebeklerin annelerinde gestasyonel % 84,9 veya insüline bağımlı diabetes mellitus GDM İDDM % 15.1 saptandı. Annelerin ortalama yaşı 31,2 yıl, glikolize hemoglobin HbA1c median değerleri ise 5,9 % 5,0-7,9% idi. Gebelik süresi içerisinde annelerin % 11,6’sında hipertansiyon, % 5,8’inde preeklampsi ve % 3,5’inde polihidroamniyoz gözlenirken, % 60,8’inde ek bir komplikasyon saptanmadı. Annelerin ortalama gebelik süresi süresi 37,9±1,9 haftayken, doğumların % 82,6 n=71 ‘sı zamanında, % 17,4 n=15 ’ü ise preterm olarak gerçekleşti. Sezaryen doğum oranı % 31,4, bebeklerin ortalama doğum ağırlığı 3500 gr bulundu. Çalışmada bebeklerin 44 % 51,2 ’ü, erkek, 42 % 48,8 ’si kız cinsiyetinde iken, makrozomi sıklığı % 34,9 idi. Bebeklerde RDS % 4,6 n=4 , konjestif kalp yetmezliği % 10,4 n=9 , hipoksik iskemik ensefalopati % 10,4 n=9 , brakiyal pleksus paralizisi % 3,5 n=3 , hipoglisemi % 32,5 n=28 , polisitemi % 27,9 n=24 , indirekt hiperbilirubinemi % 25,5 n=22 ve hipokalsemi % 11,6 n=10 oranında bulundu. Tromboz 14 % 16,2 vakada saptandı. Annenin HbA1c düzeyi ile RDS, hipoglisemi, hipokalsemi ve polisitemi gelişimi arasında bir ilişki saptanmazken p>0,05 , HbA1c düzeyi arttıkça majör anomali sıklığında artış görüldü p

Anahtar Kelimeler

• Diyabetik anne bebeği,komplikasyonlar,morbidite,mortalite

A Seven Year Experience On Infants of Diabetic Mothers In A Neonatal Intensive Care Unit

Öz

Objective: Diabetes is an important disease causing an adverse effect of fetal development during pregnancy and metabolic defects in newborn babies. In this study, it was aimed to determine the metabolic and systemic complications of infants of diabetic mothers with pregnancy follow-ups.Material and Method: Clinical findings and laboratory data with mothers’ sociodemographic properties were evaluated in neonates with the diagnosis of infants of diabetic mothers IDM that were followed in our clinic between January 2005-December 2011. Results: During the study period, 86 neonates were diagnosed with IDM. The incidence of gestational diabetes mellitus GDM of the mothers of these infants was 84.9% and the incidence of insulin dependent diabetes mellitus IDDM was 15.1 %. Mothers’ mean age was 31.2 years and the mean value of glycated hemoglobin HbA1c was 5.9 5.0-7.9 . Hypertension 11.6 % , preeclampsia 5.8 % and polyhydroamniosis 3.5 % incidences were detected in mothers while there was no additional complication in 60.8 % of the mothers. Mean pregnancy duration of the mothers was 37.9±1.9 weeks, while the incidence of term , and preterm births were 82.6 % n=71 and 17.4 % n=15 , respectively. The frequency of the cesarian section was 31.4 % and the mean birth weights of the babies were found as 3500 g 1200-5259 g . Babies were of male 51.2 %: n=44 , female 48.8 %: n=42 gender, while macrosomia 34.9 % . RDS 4.6 %: n=4 , congestive heart failure 10.4 % :n=9 , hypoxic ischemic encephalopathy 10.4 % : n=9 , brachial plexus paralysis 3.5 %: n=3 , hypoglycemia 32.5 % n=28 , polycythemia 27.9 %: n=24 , indirect hyperbilirubinemia 25.5 %: n=22 , and hypocalcemia 11.6 %: n=10 were detected in babies. Thrombosis was found to be in 14 16.2 % infants. There was no correlation between the level of HbA1c of mothers and RDS, hypogycemia, hypocalcemia and polycythemia p>0.05 , while the incidence of major malformation was seemed to rise with the increase of HbA1c level p

Anahtar Kelimeler

• Infant of diabetic mother,complications,morbidity,mortality

Kaynakça

1. Cowent RM, Schwartz R. The infant of the diabetic mother. Pediatr Clin North Am 1982;29(5):1213-31.
2. American College of Obstetricians and Gynecologists Committee on Practice Bulletins--Obstetrics. ACOG Practice Bulletin. Clinical management guidelines for obstetrician- gynecologists. Gestational diabetes. Obstet Gynecol 2001; (3):525-38. PMid:11547793
3. JM, Cubero JM, Gallo G, de Leiva A, et al. In human ges- tational diabetes mellitus congenital malformations are related to pre-pregnancy body mass index and to severity of diabetes. Diabetologia 2004;47(3):509-14. http://dx.doi.org/10.1007/s00125-004-1337-3 PMid:14770278 Clin North Am 2004;51(3):619-37. http://dx.doi.org/10.1016/j.pcl.2004.01.003 PMid:15157588 short-term outcomes. Semin Fetal Neonatal Med 2009;14(2): 8. http://dx.doi.org/10.1016/j.siny.2008.11.007 PMid:19249005
4. Neonatoloji 2. Baskı Nobel Tıp 2007; 741-6. complicating pregnancy. Obstet Gynecol Clin North Am ;28(3):513-36. http://dx.doi.org/10.1016/S0889-8545(05)70215-1
5. Rajdl D, Racek J, Steinerova A, et al. Markers of oxidative stres in diabetic mothers and their infants during delivery. Physiol Res 2005;54(4):429-36. PMid:15588143 for women with pre-gestational diabetes mellitus: a systematic review and meta-analysis. BMC Public Health 2012;12(1):792- http://dx.doi.org/10.1186/1471-2458-12-792 PMid:22978747 PMCid:3575330
6. DR, Dyer AR, Metzger BE, et al. HAPO Study Cooperative Research Group. The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with preg- nancy outcomes. Diabetes Care 2012;35(4):780-6. http://dx.doi.org/10.2337/dc11-1790 PMid:22357187
7. Martin JR, Fanaroff AA, Walsh MC. Fanaroff & Martin’s (eds) Neonatal-Perinatal Medicine. 9th ed. Vol.1 St. Louis, Missouri: Saunders Elsevier (Mosby); 2011.p.1308-1310.
8. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999;103(1):6-14. http://dx.doi.org/10.1542/peds.103.1.6 PMid:9917432

9. Hyperbilirubinemia Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics ;114(1):297-316. http://dx.doi.org/10.1542/peds.114.1.297 PMid:15231951 concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care 2007;30(7):1920-5. http://dx.doi.org/10.2337/dc07-0278 PMid:17446531
10. Plasma ghrelin and resistin concentrations are suppressed in infants of insulin-dependent diabetic mothers. J Clin Endocrinol Metab 2004;89(11):5563-8. http://dx.doi.org/10.1210/jc.2004-0736 PMid:15531512
11. Pietryga M, Szczapa J, Biczysko R. Threshold values of maternal blood glucose in early diabetic pregnancy-prediction of fetal malformations. Acta Obstet Gynecol Scand 2005; (1):17-25. PMid:15603562
12. Behrman RE, Kliegman RM, Jenson HB (eds)19th ed. Nelson Textbook of Pediatrics. Philadelphia: Saunders; 2011. p. 613
13. DL. Neonatal outcomes of macrosomic births in diabetic and non-diabetic women. Arch Dis Child Fetal Neonatal Ed. ;94(6):419-22. http://dx.doi.org/10.1136/adc.2008.156026 PMid:19531522 Diab Rep 2012;12(1):4-15. http://dx.doi.org/10.1007/s11892-011-0243-6 PMid:22094826